Friday 6 November 2026 Export DOCS’s income statement to Excel — free account

Doximity, Inc.

DOCS Healthcare Health Information Services

Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.

Revenue: +3.57%
EPS: −42.4%
Free cash flow: +1.87%

Quarter to September 2026, against a year earlier

32.10 1.08 −3.25%

Follow DOCS

Alert me

Market cap: $5.9B
P/E: 44.4×
Fwd P/E: 49.7×
Dividend yield: —
F-score: 5/9
Altman Z: 17.11
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Doximity, Inc. (DOCS) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2026: revenue by products and services, and margins
Subscription	608	94.35%
Other	36	5.65%
Gross margin		89.09%
Operating margin		33.33%
Pre-tax margin		38.77%

Revenue by product or service $m

Line	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Subscription	608 94.35%	544 95.33%	450 94.67%	390 93.00%	319 92.94%	192 92.92%	116 100.00%
Other	36 5.65%	27 4.67%	25 5.33%	29 7.00%	24 7.06%	15 7.08%	0 0.00%
Revenue	645	570	475	419	344	207	116

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Unique active prescribers	Q4 FY2026	800.0K	—	—

	Q4 FY2026	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q2 FY2025
Unique active prescribers	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.